Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000897069-25-000292
Filing Date
2025-02-18
Accepted
2025-02-18 17:54:50
Documents
1
Period of Report
2025-02-17

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 7137
  Complete submission text file 0000897069-25-000292.txt   8658
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address
Lin Patrick (Reporting) CIK: 0001799363 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39531 | Film No.: 25636456